HIV/AIDS: No Cure, But Effective Long-Term Control with ART

There is currently no cure for HIV/AIDS. HIV integrates into host genome, establishing latent reservoirs that persist despite therapy. However, modern treatment transforms HIV into a manageable chronic condition.

Antiretroviral Therapy (ART): The Standard of Care

  • Goal: Suppress plasma HIV RNA to undetectable (<50 copies/mL, or <20 with ultrasensitive assays).
  • Regimens: 2–3 drug combinations (INSTI + 2 NRTIs preferred: bictegravir/tenofovir alafenamide/emtricitabine, dolutegravir/lamivudine). Single-tablet, once-daily, high barrier to resistance.
  • Initiation: Same-day/rapid start recommended at diagnosis (improves retention, faster suppression).
  • Monitoring: Viral load at 4–8 weeks, then every 3–6 months; CD4 count every 3–6 months until >500, then annually.

Outcomes with Sustained Suppression

  • Life expectancy: Near-normal if diagnosed early, treated promptly, and adherent.
  • U=U (Undetectable = Untransmittable): Zero risk of sexual transmission to partners. Major public health and stigma-reduction milestone.
  • Immune recovery: CD4 restoration reduces OI risk; non-AIDS comorbidities (CVD, renal, bone, neurocognitive) become primary focus.
  • Quality of life: Comparable to general population with modern, well-tolerated regimens.

Challenges & Emerging Directions

  • Adherence barriers: Stigma, cost, access, mental health, substance use, pill fatigue.
  • Long-acting injectables: Cabotegravir + rilpivirine (monthly/every-2-months) for virologically suppressed adults.
  • Cure research: "Shock and kill," "block and lock," gene editing (CRISPR), broadly neutralizing antibodies, therapeutic vaccines—still experimental.
  • Aging with HIV: Multimorbidity, polypharmacy, frailty, cognitive decline—requires geriatric-HIV integration.

Key Message

HIV is not a death sentence. With early diagnosis, ART access, and adherence, people with HIV live long, healthy lives and cannot sexually transmit the virus. Testing, linkage to care, and retention are critical.

HIV & AIDS - Related Articles